The nutrigenomics market is expected to register a CAGR of 16% during the forecast period, up from US$ 451.7 Million in 2021 to reach a valuation of US$ 2311.49 Million by 2032.
The nutrigenomics market is anticipated to show promising growth prospects during the forecasted period owing to the rising burden of nutrition-related non-communicable illnesses.
| Attributes | Details |
|---|---|
| Nutrigenomics Market CAGR | 16% |
| Nutrigenomics Market Value 2021 | US$ 451.7 Million |
| Nutrigenomics Market Projected Value 2032 | US$ 2311.49 Million |
The nutrigenomics market is also predicted to rise due to the rising prevalence of cardiovascular illnesses and obesity among the growing population. Cardiovascular disorders, according to the World Health Organization (WHO), are one of the main causes of mortality worldwide, killing an estimated 17.9 million people each year.
As a result, the global nutrigenomics market share is anticipated to rise during the forecasted period. During the forecast period, rising cancer prevalence among the growing population is expected to fuel the demand for nutrigenomics.
The rising popularity of tailored nutrition among athletes is projected to fuel the demand for nutrigenomics.
The popularity of personalized nutrition among athletes is due to its goal of optimizing exercise performance, energy output, and health by tailoring nutritional recommendations to an individual's genetic profile. This is promoting the sales of nutrigenomics and supports the overall nutrigenomics market share.
The shift away from a one-size-fits-all approach to the personalization of diets among sports dietitians and nutritionists is promoting growth for the nutrigenomics market. Another element boosting the sales of nutrigenomics in the sports sector is its ability to deliver information about recommended dietary choices that are more successful at an individual level than current dietary guidance.
The report sheds light on the factors improving the sales of nutrigenomics, and, in turn, the opportunities for the market players. However, the nutrigenomics market also faces some challenges, which might limit the nutrigenomics market share from reaching its potential.
Some of the key nutrigenomics market trends promoting the demand for nutrigenomics include rising consumer awareness of nutrition habits, healthy food, and intake of functional foods that have a good physiologic effect and postpone or prevent the onset of chronic diseases.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The increase in the prevalence of diabetes and other chronic diseases is anticipated to increase the demand for nutrigenomics and propel the growth of the overall nutrigenomics market share.
According to the World Health Organization, in 2016, approximately 1.6 million deaths occurred due to diabetes which was the seventh leading cause of death in the world. Chronic diseases are the major factors due to which demand for nutrigenomics is rising.
In 2020, chronic diseases rose up to 73% of the total deaths. The most common chronic diseases are cardiovascular diseases, cancer, and diabetes. As health awareness is increasing, consumers are willing to pay more so as to live a healthy lifestyle.
The demand for personalized products is anticipated to increase to reduce the risk of diseases and disorders. The demand for personalized products is anticipated to boost the demand for nutrigenomics.
In the North American region, the demand for nutrigenomics is expected to expand rapidly. Obesity is expected to affect roughly 42 percent of the population in America by 2030, according to the Centers for Disease Control and Prevention (CDC).
As public awareness of obesity rises, consumers' willingness to adopt customized products is expected to rise as well. The rising prevalence of diabetes and obesity is expected to be a major driver propelling the demand for nutrigenomics.
According to the WHO, the number of people living with diabetes in India is expected to reach 79 million by 2030. Malaysia has a major obesity problem and is the country with the highest prevalence of diabetes and obesity in Southeast Asia. As a result, the rising prevalence of diabetes and obesity in Southeast Asia is expected to boost the nutrigenomics market growth. The Asia Pacific area also presents an excellent opportunity for nutrigenomics service providers.
Principal Consultant
Key players operating in the global nutrigenomics market are Vitagene, Mapmygenome, Gini Health, geneOmbio, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., and Xcode Life.
In recent years, key players in the nutrigenomics market are trying to use nutrigenomics to optimize the nutrition intake that would help in reducing the chances of diseases at all stages of life. The increasing demand for healthy personalized products is expected to increase the inclination of food manufacturers towards the use of nutrigenomics so as to formulate personalized products, which is estimated to increase the demand for nutrigenomics in the food industry.
The report consists of key players contributing to the nutrigenomics market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions. This exclusive report analyzes the competitive landscape and nutrigenomics market share acquired by players to strengthen their market position.
Recent Developments in the Nutrigenomics Market:
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 16% from 2022 to 2032 |
| The base year for estimation | 2021 |
| Historical data | 2015 to 2020 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments Covered | Application, End users, Region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia, and New Zealand |
| Country scope | USA; Canada; Mexico; Germany; United Kingdom; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; United Arab Emirates; Iran; South Africa |
| Key companies profiled | Vitagene, Mapmygenome, Gini Health, geneOmbio, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., Xcode Life |
| Customization scope | Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The nutrigenomics market is predicted to register a CAGR of 16% during the forecast period.
Key players holding substantial nutrigenomics market share include Vitagene, Mapmygenome, Gini Health, geneOmbio, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., and Xcode Life.
As per the analysis, the nutrigenomics market share is likely to be US$ 2311.49 Million by 2032.
Demand for nutrigenomics is likely to rise due to the prevalence of cardiovascular illnesses and obesity among the growing population
1. Executive Summary | Nutrigenomic Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. Value Chain Analysis 3.5.1. Profit Margin Analysis 3.5.2. Service Providers 3.6. PESTLE and Porter’s Analysis 3.7. Regulatory Landscape 3.7.1. By Key Regions 3.7.2. By Key Countries 3.8. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Service Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Service Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service Type, 2022 to 2032 5.3.1. Genetic Testing Service 5.3.2. Personalized Diet Service 5.3.3. International 5.4. Y-o-Y Growth Trend Analysis By Service Type, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Service Type, 2022 to 2032 Deep-dive segmentation will be available in the sample on request 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032 6.3.1. Dieticians 6.3.2. Sports Clinics 6.3.3. Corporate Programs 6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032 Deep-dive segmentation will be available in the sample on request 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia & Pacific 7.3.6. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Service Type 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Service Type 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. Mexico 9.2.1.2. Brazil 9.2.1.3. Rest of Latin America 9.2.2. By Service Type 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Service Type 9.3.3. By End User 9.4. Key Takeaways 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. Italy 10.2.1.3. France 10.2.1.4. United Kingdom 10.2.1.5. Spain 10.2.1.6. BENELUX 10.2.1.7. Russia 10.2.1.8. Rest of Europe 10.2.2. By Service Type 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Service Type 10.3.3. By End User 10.4. Key Takeaways 11. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.2. By Service Type 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Service Type 11.3.3. By End User 11.4. Key Takeaways 12. South Asia & Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. ASEAN 12.2.1.3. Australia and New Zealand 12.2.1.4. Rest of South Asia & Pacific 12.2.2. By Service Type 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Service Type 12.3.3. By End User 12.4. Key Takeaways 13. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. Turkey 13.2.1.3. South Africa 13.2.1.4. Rest of Middle East and Africa 13.2.2. By Service Type 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Service Type 13.3.3. By End User 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. USA 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Service Type 14.1.2.2. By End User 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Service Type 14.2.2.2. By End User 14.3. Mexico 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Service Type 14.3.2.2. By End User 14.4. Brazil 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Service Type 14.4.2.2. By End User 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Service Type 14.5.2.2. By End User 14.6. Italy 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Service Type 14.6.2.2. By End User 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Service Type 14.7.2.2. By End User 14.8. United Kingdom 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Service Type 14.8.2.2. By End User 14.9. Spain 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Service Type 14.9.2.2. By End User 14.10. BENELUX 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Service Type 14.10.2.2. By End User 14.11. Russia 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Service Type 14.11.2.2. By End User 14.12. China 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Service Type 14.12.2.2. By End User 14.13. Japan 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Service Type 14.13.2.2. By End User 14.14. South Korea 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Service Type 14.14.2.2. By End User 14.15. India 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Service Type 14.15.2.2. By End User 14.16. ASIAN 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Service Type 14.16.2.2. By End User 14.17. Australia and New Zealand 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Service Type 14.17.2.2. By End User 14.18. GCC Countries 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Service Type 14.18.2.2. By End User 14.19. Turkey 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Service Type 14.19.2.2. By End User 14.20. South Africa 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2021 14.20.2.1. By Service Type 14.20.2.2. By End User 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Service Type 15.3.3. By End User 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. DayTwo, Inc. 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. DNA Fit 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. DNAlysis Biotechnology 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Genomix Nutrition, Inc. 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Habit Food Personalized, LLC 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. LifeNome, Inc. 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Nutrigenomix, Inc. 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. Personalized Nutrition Concierges 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Psomagen-Macrogen Consortium 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Vitagene 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Food and Beverage Insights
View Reports
Nutrigenomic Market
